Dr. Lal PathLabs Limited
LALPATHLAB
Peringkat dalam Saham
#4526
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health... Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its widespread infrastructure included 277 clinical laboratories, notably a National Reference Lab located in Delhi and a Regional Reference Lab in Kolkata. This is further bolstered by 4,731 patient service centers and 10,599 sample collection points. Founded in 1949, Dr. Lal PathLabs Limited maintains its corporate base in Gurugram, India.
Harga Saham
$20.35
Terakhir disinkronkan: 2026-10-19
Kapitalisasi Pasar
$3.40B
Perubahan (1 hari)
-0.86%
Perubahan (1 tahun)
13.63%
Negara
IN
Perdagangan Dr. Lal PathLabs Limited (LALPATHLAB)
Kategori
Healthcare
Rasio P/E untuk Dr. Lal PathLabs Limited (LALPATHLAB)
Rasio P/E per October 2026 TTM: 57.71
Menurut laporan keuangan dan harga saham terbaru dari Dr. Lal PathLabs Limited, rasio P/E saat ini (TTM) adalah 57.71. Pada akhir 2024, perusahaan memiliki rasio P/E sebesar 53.24.
Riwayat rasio P/E untuk Dr. Lal PathLabs Limited dari 2011 hingga 2026
Rasio P/E di akhir setiap tahun
| Tahun | Rasio P/E | Mengubah |
|---|---|---|
| 2026 (TTM) | 57.71 | 40.44% |
| 2025 | 41.09 | -22.83% |
| 2024 | 53.24 | -16.09% |
| 2023 | 63.45 | 1.34% |
| 2022 | 62.61 | -18.29% |
| 2021 | 76.62 | 49.90% |
| 2020 | 51.12 | 17.78% |
| 2019 | 43.40 | 3.81% |
| 2018 | 41.81 | -18.03% |
| 2017 | 51.00 | -11.11% |
| 2016 | 57.38 | 21.27% |
| 2015 | 47.32 | -44.77% |
| 2014 | 85.67 | -30.73% |
| 2013 | 123.67 | -18.90% |
| 2012 | 152.48 | -34.87% |
| 2011 | 234.14 | 0.00% |
Rasio P/E untuk perusahaan serupa atau pesaing
| Perusahaan | Rasio P/E | Perbedaan Rasio P/E | Negara |
|---|---|---|---|
| 36.15 | -37.35% |
US
|
|
| 39.77 | -31.08% |
US
|
|
| -290.26 | -602.99% |
US
|
|
| - | - |
CN
|
|
| 34.18 | -40.76% |
US
|
Bagaimana cara membaca P/E ratio?
Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.
Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.
Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.